Dabeeru C. Rao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dabeeru C. Rao has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Aldi T. Kraja
Division of Statistical Genomics, Washington University School of Medicine, Saint Louis, Missouri, USA
7 shared publications - Donna K. Arnett
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, USA
7 shared publications - Chi Charles Gu
Division of Biology & Biomedical Sciences, Washington University School of Medicine, St. Louis, USA
6 shared publications - Treva Rice
Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri 63110, USA
6 shared publications - Yun Ju Sung
Division of Biostatistics Washington University School of Medicine St. Louis Missouri United States of America
6 shared publications - Michael A. Province
Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, USA
5 shared publications
Latest Publications
- Open Access
- 20 June 2015
- Published by Springer Nature in BMC Genomic Data
- Vol. 16  (1) , 64
Aggregate blood pressure responses to serial dietary sodium and potassium intervention: defining responses using independent component analysis
- 20 June 2015
- Published by Springer Nature in BMC Genomic Data
- Vol. 16  (1) , 64
Open AccessAggregate blood pressure responses to serial dietary sodium and potassium intervention: defining responses using independent component analysis
- Open Access
- 17 June 2014
- Published by Springer Nature in BMC Proceedings
- Vol. 8  (S1) , S12
Whole genome sequence analysis of the simulated systolic blood pressure in Genetic Analysis Workshop 18 family data: long-term average and collapsing methods
Analysis of longitudinal family data is challenging because of 2 sources of correlations: correlations across longitudinal measurements and correlations among related individuals. We investigated whether analysis using long-term average (average of all 3 visits) can enhance gene discovery compared with a single-visit analysis. We analyzed all 200 replicates of simulated systolic blood pressure (SBP) in Genetic Analysis Workshop 18 (GAW18) family data using both single-marker and collapsing methods. We considered 2 collapsing approaches: collapsing all variants and collapsing low-frequency variants. Analysis using long-term average performed slightly better than SBP measured at a single visit. Collapsing all variants performed much better than collapsing low-frequency variants at MAP4 and FLNB, which included a common variant with a relatively large effect. For several variants in gene MAP4, single-marker analysis also provided high power. In contrast, collapsing only low-frequency variants performed much better for SCAP, DNASE1L3, and LOC152217, where rare variants in these genes had larger effect than common variants. However, for other causal variants, all approaches provided disappointingly poor performance. This poor performance appeared to occur because most of these causal variants explained a very small fraction of phenotypic variance. We also found that collapsing multiple variants did worse than single-marker analysis for several genes when they contained causal single-nucleotide polymorphisms (SNPs) with both positive and negative effects. Because half of causal SNPs were not found in the annotation file based on the 1000 Genomes Project, we found that power was also affected by our use of incomplete annotation information.
- 17 June 2014
- Published by Springer Nature in BMC Proceedings
- Vol. 8  (S1) , S12
Open AccessWhole genome sequence analysis of the simulated systolic blood pressure in Genetic Analysis Workshop 18 family data: long-term average and collapsing methods
Analysis of longitudinal family data is challenging because of 2 sources of correlations: correlations across longitudinal measurements and correlations among related individuals. We investigated whether analysis using long-term average (average of all 3 visits) can enhance gene discovery compared with a single-visit analysis. We analyzed all 200 replicates of simulated systolic blood pressure (SBP) in Genetic Analysis Workshop 18 (GAW18) family data using both single-marker and collapsing methods. We considered 2 collapsing approaches: collapsing all variants and collapsing low-frequency variants. Analysis using long-term average performed slightly better than SBP measured at a single visit. Collapsing all variants performed much better than collapsing low-frequency variants at MAP4 and FLNB, which included a common variant with a relatively large effect. For several variants in gene MAP4, single-marker analysis also provided high power. In contrast, collapsing only low-frequency variants performed much better for SCAP, DNASE1L3, and LOC152217, where rare variants in these genes had larger effect than common variants. However, for other causal variants, all approaches provided disappointingly poor performance. This poor performance appeared to occur because most of these causal variants explained a very small fraction of phenotypic variance. We also found that collapsing multiple variants did worse than single-marker analysis for several genes when they contained causal single-nucleotide polymorphisms (SNPs) with both positive and negative effects. Because half of causal SNPs were not found in the annotation file based on the 1000 Genomes Project, we found that power was also affected by our use of incomplete annotation information.
- Open Access
- 1 January 2014
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 5, 9
Comparison of two methods for analysis of gene–environment interactions in longitudinal family data: the Framingham heart study
GxE interaction analysis can potentially enhance gene discovery for common complex traits. However, genome-wide interaction analysis (GWIS) is computationally intensive. Moreover, analysis of longitudinal data in families is much more challenging due to the two sources of correlations arising from longitudinal measurements and family relationships. GWIS of longitudinal family data can be a computational bottleneck. Therefore, we compared two methods for analysis of longitudinal family data: a methodologically sound but computationally demanding method using the Kronecker Model (KRC) and a computationally more forgiving method using the Hierarchical Linear Model (HLM). The KRC model uses a Kronecker product of an unstructured matrix for correlations among repeated measures (longitudinal) and a compound symmetry matrix for correlations within families at a given visit. The HLM uses an autoregressive covariance matrix for correlations among repeated measures and a random intercept for familial correlations. We compared the two methods using the longitudinal Framingham Heart Study (FHS) SHARe data. Specifically, we evaluated SNP-Alcohol (amount of alcohol consumption) interaction effects on HDL-cholesterol. Keeping the prohibitive computational burden of KRC in mind, we limited the analysis to chromosome 16, where preliminary cross-sectional analysis yielded some interesting results. Our first important finding was that the HLM provided very comparable results but was remarkably faster than the KRC, making HLM the method of choice. Our second finding was that longitudinal analysis provided smaller p values, thus leading to more significant results, than cross-sectional analysis. This was particularly pronounced in identifying GxE interactions. We conclude that longitudinal analysis of GxE interactions is more powerful and that the HLM method is an optimal method of choice as compared to the computationally (prohibitively) intensive KRC method.
- 1 January 2014
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 5, 9
Open AccessComparison of two methods for analysis of gene–environment interactions in longitudinal family data: the Framingham heart study
GxE interaction analysis can potentially enhance gene discovery for common complex traits. However, genome-wide interaction analysis (GWIS) is computationally intensive. Moreover, analysis of longitudinal data in families is much more challenging due to the two sources of correlations arising from longitudinal measurements and family relationships. GWIS of longitudinal family data can be a computational bottleneck. Therefore, we compared two methods for analysis of longitudinal family data: a methodologically sound but computationally demanding method using the Kronecker Model (KRC) and a computationally more forgiving method using the Hierarchical Linear Model (HLM). The KRC model uses a Kronecker product of an unstructured matrix for correlations among repeated measures (longitudinal) and a compound symmetry matrix for correlations within families at a given visit. The HLM uses an autoregressive covariance matrix for correlations among repeated measures and a random intercept for familial correlations. We compared the two methods using the longitudinal Framingham Heart Study (FHS) SHARe data. Specifically, we evaluated SNP-Alcohol (amount of alcohol consumption) interaction effects on HDL-cholesterol. Keeping the prohibitive computational burden of KRC in mind, we limited the analysis to chromosome 16, where preliminary cross-sectional analysis yielded some interesting results. Our first important finding was that the HLM provided very comparable results but was remarkably faster than the KRC, making HLM the method of choice. Our second finding was that longitudinal analysis provided smaller p values, thus leading to more significant results, than cross-sectional analysis. This was particularly pronounced in identifying GxE interactions. We conclude that longitudinal analysis of GxE interactions is more powerful and that the HLM method is an optimal method of choice as compared to the computationally (prohibitively) intensive KRC method.
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 4, 277
Gene-alcohol interactions identify several novel blood pressure loci including a promising locus near SLC16A9
Alcohol consumption is a known risk factor for hypertension, with recent candidate studies implicating gene-alcohol interactions in blood pressure (BP) regulation. We used 6,882 (predominantly) Caucasian participants aged 20 to 80 years from the Framingham SHARe (SNP Health Association Resource) to perform a genome-wide analysis of SNP-alcohol interactions on BP traits. We used a two-step approach in the ABEL suite to examine genetic interactions with three alcohol measures [ounces of alcohol consumed per week, drinks consumed per week, and the number of days drinking alcohol per week] on four BP traits [systolic (SBP), diastolic (DBP), mean arterial (MAP), and pulse (PP) pressure]. In the first step, we fit a linear mixed model of each BP trait onto age, sex, BMI, and antihypertensive medication while accounting for the phenotypic correlation among relatives. In the second step, we conducted 1 degree-of-freedom (df) score tests of the SNP main effect, alcohol main effect, and SNP-alcohol interaction using the maximum likelihood estimates of the parameters from the first step. We then calculated the joint 2 df score test of the SNP main effect and SNP-alcohol interaction using MixABEL. The effect of SNP rs10826334 (near SLC16A9) on SBP was significantly modulated by both the number of alcoholic drinks and the ounces of alcohol consumed per week (p-values of 1.27E-08 and 3.92E-08, respectively). Each copy of the G-allele decreased SBP by 3.79 mmHg in those consuming 14 drinks per week versus a 0.461 mmHg decrease in non-drinkers. Index SNPs in 20 other loci exhibited suggestive (p-value≤1E-06) associations with BP traits by the 1 df interaction test or joint 2df test, including 3 rare variants, one low-frequency variant, and SNPs near/in genes ESRRG, FAM179A, CRIPT-SOCS5, KAT2B,ADCY2, GLI3, ZNF716, SLIT1, PDE3A, KERA-LUM, RNF219-AS1, CLEC3A , FBX015, and IGSF5. SNP -alcohol interactions may enhance discovery of novel variants with large effects that can be targeted
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 4, 277
Open AccessGene-alcohol interactions identify several novel blood pressure loci including a promising locus near SLC16A9
Alcohol consumption is a known risk factor for hypertension, with recent candidate studies implicating gene-alcohol interactions in blood pressure (BP) regulation. We used 6,882 (predominantly) Caucasian participants aged 20 to 80 years from the Framingham SHARe (SNP Health Association Resource) to perform a genome-wide analysis of SNP-alcohol interactions on BP traits. We used a two-step approach in the ABEL suite to examine genetic interactions with three alcohol measures [ounces of alcohol consumed per week, drinks consumed per week, and the number of days drinking alcohol per week] on four BP traits [systolic (SBP), diastolic (DBP), mean arterial (MAP), and pulse (PP) pressure]. In the first step, we fit a linear mixed model of each BP trait onto age, sex, BMI, and antihypertensive medication while accounting for the phenotypic correlation among relatives. In the second step, we conducted 1 degree-of-freedom (df) score tests of the SNP main effect, alcohol main effect, and SNP-alcohol interaction using the maximum likelihood estimates of the parameters from the first step. We then calculated the joint 2 df score test of the SNP main effect and SNP-alcohol interaction using MixABEL. The effect of SNP rs10826334 (near SLC16A9) on SBP was significantly modulated by both the number of alcoholic drinks and the ounces of alcohol consumed per week (p-values of 1.27E-08 and 3.92E-08, respectively). Each copy of the G-allele decreased SBP by 3.79 mmHg in those consuming 14 drinks per week versus a 0.461 mmHg decrease in non-drinkers. Index SNPs in 20 other loci exhibited suggestive (p-value≤1E-06) associations with BP traits by the 1 df interaction test or joint 2df test, including 3 rare variants, one low-frequency variant, and SNPs near/in genes ESRRG, FAM179A, CRIPT-SOCS5, KAT2B,ADCY2, GLI3, ZNF716, SLIT1, PDE3A, KERA-LUM, RNF219-AS1, CLEC3A , FBX015, and IGSF5. SNP -alcohol interactions may enhance discovery of novel variants with large effects that can be targeted
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 4, 304
The role of SNP-loop diuretic interactions in hypertension across ethnic groups in HyperGEN
Blood pressure (BP) is significantly influenced by genetic factors; however, less than 3% of the BP variance has been accounted for by variants identified from genome-wide association studies (GWAS) of primarily European-descent cohorts. Other genetic influences, including gene-environment (GxE) interactions, may explain more of the unexplained variance in BP. African Americans (AA) have a higher prevalence and earlier age of onset of hypertension (HTN) as compared with European Americans (EA); responses to anti-hypertensive drugs vary across race groups. To examine potential interactions between the use of loop diuretics and HTN traits, we analyzed systolic (SBP) and diastolic (DBP) blood BP from 1,222 AA and 1,231 EA participants in the Hypertension Genetic Epidemiology Network (HyperGEN). Population-specific score tests were used to test associations of SBP and DBP, using a panel of genotyped and imputed single nucleotide polymorphisms (SNPs) for African Americans (2.9 million SNPs) and European Americans (2.3 million SNPs). Several promising loci were identified through gene-loop diuretic interactions, although no SNP reached genome-wide significance after adjustment for genomic inflation. In AA, SNPs in or near the genes NUDT12, CHL1, GRIA1, CACNB2, and PYHIN1 were identified for SBP, and SNPs near ID3 were identified for DBP. For EA, promising SNPs for SBP were identified in ESR1and for DBP in SPATS2L and EYA2. Among these SNPs, none were common across phenotypes or population groups. Biologic plausibility exists for many of the identified genes, suggesting that these are candidate genes for regulation of BP and/or anti-hypertensive drug response. The lack of genome-wide significance is understandable in this small study employing gene-drug interactions. These findings provide a set of prioritized SNPs/candidate genes for future studies in HTN. Studies in more diversified population samples may help identify previously missed variants.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 4, 304
Open AccessThe role of SNP-loop diuretic interactions in hypertension across ethnic groups in HyperGEN
Blood pressure (BP) is significantly influenced by genetic factors; however, less than 3% of the BP variance has been accounted for by variants identified from genome-wide association studies (GWAS) of primarily European-descent cohorts. Other genetic influences, including gene-environment (GxE) interactions, may explain more of the unexplained variance in BP. African Americans (AA) have a higher prevalence and earlier age of onset of hypertension (HTN) as compared with European Americans (EA); responses to anti-hypertensive drugs vary across race groups. To examine potential interactions between the use of loop diuretics and HTN traits, we analyzed systolic (SBP) and diastolic (DBP) blood BP from 1,222 AA and 1,231 EA participants in the Hypertension Genetic Epidemiology Network (HyperGEN). Population-specific score tests were used to test associations of SBP and DBP, using a panel of genotyped and imputed single nucleotide polymorphisms (SNPs) for African Americans (2.9 million SNPs) and European Americans (2.3 million SNPs). Several promising loci were identified through gene-loop diuretic interactions, although no SNP reached genome-wide significance after adjustment for genomic inflation. In AA, SNPs in or near the genes NUDT12, CHL1, GRIA1, CACNB2, and PYHIN1 were identified for SBP, and SNPs near ID3 were identified for DBP. For EA, promising SNPs for SBP were identified in ESR1and for DBP in SPATS2L and EYA2. Among these SNPs, none were common across phenotypes or population groups. Biologic plausibility exists for many of the identified genes, suggesting that these are candidate genes for regulation of BP and/or anti-hypertensive drug response. The lack of genome-wide significance is understandable in this small study employing gene-drug interactions. These findings provide a set of prioritized SNPs/candidate genes for future studies in HTN. Studies in more diversified population samples may help identify previously missed variants.
- 1 August 2012
- Published by Elsevier in Metabolism
- Vol. 61  (8) , 1129-1141
Obesity–insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice
- 1 August 2012
- Published by Elsevier in Metabolism
- Vol. 61  (8) , 1129-1141
Obesity–insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice
- 13 December 2011
- Published by Springer Nature in Current Hypertension Reports
- Vol. 14  (1) , 46-61
Between Candidate Genes and Whole Genomes: Time for Alternative Approaches in Blood Pressure Genetics
Blood pressure has a significant genetic component, but less than 3% of the observed variance has been attributed to genetic variants identified to date. Candidate gene studies of rare, monogenic hypertensive syndromes have conclusively implicated several genes altering renal sodium balance, and studies of essential hypertension have inconsistently implicated over 50 genes in pathways affecting renal sodium balance and other functions. Genome-wide linkage scans have replicated numerous quantitative trait loci throughout the genome, and over 50 single nucleotide polymorphisms (SNPs) have been replicated in multiple genome-wide association studies. These studies provide considerable evidence that epistasis and other interactions play a role in the genetic architecture of blood pressure regulation, but candidate gene studies have limited scope to test for epistasis, and genome-wide studies have low power for both main effects and interactions. This review summarizes the genetic findings to date for blood pressure, and it proposes focused, pathway-based approaches involving epistasis, gene-environment interactions, and next-generation sequencing to further the genetic dissection of blood pressure and hypertension.
- 13 December 2011
- Published by Springer Nature in Current Hypertension Reports
- Vol. 14  (1) , 46-61
Between Candidate Genes and Whole Genomes: Time for Alternative Approaches in Blood Pressure Genetics
Blood pressure has a significant genetic component, but less than 3% of the observed variance has been attributed to genetic variants identified to date. Candidate gene studies of rare, monogenic hypertensive syndromes have conclusively implicated several genes altering renal sodium balance, and studies of essential hypertension have inconsistently implicated over 50 genes in pathways affecting renal sodium balance and other functions. Genome-wide linkage scans have replicated numerous quantitative trait loci throughout the genome, and over 50 single nucleotide polymorphisms (SNPs) have been replicated in multiple genome-wide association studies. These studies provide considerable evidence that epistasis and other interactions play a role in the genetic architecture of blood pressure regulation, but candidate gene studies have limited scope to test for epistasis, and genome-wide studies have low power for both main effects and interactions. This review summarizes the genetic findings to date for blood pressure, and it proposes focused, pathway-based approaches involving epistasis, gene-environment interactions, and next-generation sequencing to further the genetic dissection of blood pressure and hypertension.
- Open Access
- 29 November 2011
- Published by Springer Nature in BMC Proceedings
- Vol. 5  (S9) , S82
Enriching rare variants using family-specific linkage information
Genome-wide association studies have been successful in identifying common variants for common complex traits in recent years. However, common variants have generally failed to explain substantial proportions of the trait heritabilities. Rare variants, structural variations, and gene-gene and gene-environment interactions, among others, have been suggested as potential sources of the so-called missing heritability. With the advent of exome-wide and whole-genome next-generation sequencing technologies, finding rare variants in functionally important sites (e.g., protein-coding regions) becomes feasible. We investigate the role of linkage information to select families enriched for rare variants using the simulated Genetic Analysis Workshop 17 data. In each replicate of simulated phenotypes Q1 and Q2 on 697 subjects in 8 extended pedigrees, we select one pedigree with the largest family-specific LOD score. Across all 200 replications, we compare the probability that rare causal alleles will be carried in the selected pedigree versus a randomly chosen pedigree. One example of successful enrichment was exhibited for gene VEGFC. The causal variant had minor allele frequency of 0.0717% in the simulated unrelated individuals and explained about 0.1% of the phenotypic variance. However, it explained 7.9% of the phenotypic variance in the eight simulated pedigrees and 23.8% in the family that carried the minor allele. The carrier’s family was selected in all 200 replications. Thus our results show that family-specific linkage information is useful for selecting families for sequencing, thus ensuring that rare functional variants are segregating in the sequencing samples.
- 29 November 2011
- Published by Springer Nature in BMC Proceedings
- Vol. 5  (S9) , S82
Open AccessEnriching rare variants using family-specific linkage information
Genome-wide association studies have been successful in identifying common variants for common complex traits in recent years. However, common variants have generally failed to explain substantial proportions of the trait heritabilities. Rare variants, structural variations, and gene-gene and gene-environment interactions, among others, have been suggested as potential sources of the so-called missing heritability. With the advent of exome-wide and whole-genome next-generation sequencing technologies, finding rare variants in functionally important sites (e.g., protein-coding regions) becomes feasible. We investigate the role of linkage information to select families enriched for rare variants using the simulated Genetic Analysis Workshop 17 data. In each replicate of simulated phenotypes Q1 and Q2 on 697 subjects in 8 extended pedigrees, we select one pedigree with the largest family-specific LOD score. Across all 200 replications, we compare the probability that rare causal alleles will be carried in the selected pedigree versus a randomly chosen pedigree. One example of successful enrichment was exhibited for gene VEGFC. The causal variant had minor allele frequency of 0.0717% in the simulated unrelated individuals and explained about 0.1% of the phenotypic variance. However, it explained 7.9% of the phenotypic variance in the eight simulated pedigrees and 23.8% in the family that carried the minor allele. The carrier’s family was selected in all 200 replications. Thus our results show that family-specific linkage information is useful for selecting families for sequencing, thus ensuring that rare functional variants are segregating in the sequencing samples.
- Open Access
- 29 November 2011
- Published by Springer Nature in BMC Proceedings
- Vol. 5  (S9) , S121
Application of collapsing methods for continuous traits to the Genetic Analysis Workshop 17 exome sequence data
Genetic Analysis Workshop 17 used real sequence data from the 1000 Genomes Project and simulated phenotypes influenced by a large number of rare variants. Our aim is to evaluate the performance of various collapsing methods that were developed for analysis of multiple rare variants. We apply collapsing methods to continuous phenotypes Q1 and Q2 for all 200 replicates of the unrelated individuals data. Within each gene, we collapse (1) all SNPs, (2) all SNPs with minor allele frequency (MAF) < 0.05, and (3) nonsynonymous SNPs with MAF < 0.05. We consider two tests when collapsing variants: using the proportion of variants and using the presence/absence of any variant. We also compare our results to a single-marker analysis using PLINK. For phenotype Q1, the proportion test for collapsing rare nonsynonymous SNPs often performed the best. Two genes (FLT1 and KDR) had statistically significant results. A single-marker analysis using PLINK also provided statistically significant results for some SNPs within these two genes. For phenotype Q2, collapsing rare nonsynonymous SNPs performed the best, with almost no difference between proportion and presence tests. However, neither collapsing methods nor a single-marker analysis provided statistically significant results at the true genes for Q2. We also found that a large number of noncausal genes had high correlations with causal genes for Q1 and Q2, which may account for inflated false positives.
- 29 November 2011
- Published by Springer Nature in BMC Proceedings
- Vol. 5  (S9) , S121
Open AccessApplication of collapsing methods for continuous traits to the Genetic Analysis Workshop 17 exome sequence data
Genetic Analysis Workshop 17 used real sequence data from the 1000 Genomes Project and simulated phenotypes influenced by a large number of rare variants. Our aim is to evaluate the performance of various collapsing methods that were developed for analysis of multiple rare variants. We apply collapsing methods to continuous phenotypes Q1 and Q2 for all 200 replicates of the unrelated individuals data. Within each gene, we collapse (1) all SNPs, (2) all SNPs with minor allele frequency (MAF) < 0.05, and (3) nonsynonymous SNPs with MAF < 0.05. We consider two tests when collapsing variants: using the proportion of variants and using the presence/absence of any variant. We also compare our results to a single-marker analysis using PLINK. For phenotype Q1, the proportion test for collapsing rare nonsynonymous SNPs often performed the best. Two genes (FLT1 and KDR) had statistically significant results. A single-marker analysis using PLINK also provided statistically significant results for some SNPs within these two genes. For phenotype Q2, collapsing rare nonsynonymous SNPs performed the best, with almost no difference between proportion and presence tests. However, neither collapsing methods nor a single-marker analysis provided statistically significant results at the true genes for Q2. We also found that a large number of noncausal genes had high correlations with causal genes for Q1 and Q2, which may account for inflated false positives.
- Open Access
- 1 November 2011
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 24  (11) , 1227-1233
Variants on Chromosome 6p22.3 Associated With Blood Pressure in the HyperGEN Study: Follow-Up of FBPP Quantitative Trait Loci
Background. A recent meta-analysis of genome-wide linkage scans of blood pressure (BP) in the large (N = 13,044) Family Blood Pressure Program (FBPP) identifie
- 1 November 2011
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 24  (11) , 1227-1233
Open AccessVariants on Chromosome 6p22.3 Associated With Blood Pressure in the HyperGEN Study: Follow-Up of FBPP Quantitative Trait Loci
Background. A recent meta-analysis of genome-wide linkage scans of blood pressure (BP) in the large (N = 13,044) Family Blood Pressure Program (FBPP) identifie